| Name | Title | Contact Details |
|---|
Savara Inc. is an orphan lung disease company. Savara`s pipeline comprises: Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for PAP, and in Phase 2a development for NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of MRSA infection in cystic fibrosis. Savara`s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. Savara`s management team has significant experience in orphan drug development and pulmonary medicine, in identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.
Genesys Venture Inc. is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Total Care RX serves as an extension of the patient’s medical team to monitor medication compliance, provide education and offer other value-added services not offered by retail pharmacies.
RPM Systems is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ViroChem Pharma is a Laval, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.